Output

Meetings
During the year, the Child and Adolescent Neuropsychopharmacology Network organises meetings for its members (also at the annual ECNP Congress).

Research projects

• conect4children (Collaborative Network for European Clinical Trials for Children)
  European Union’s Horizon 2020 research and innovation programme and EFPIA, Grant Agreement no. 777389.
  
  
• PERS (Pediatric European Risperidone Studies)
  
  
• STOP (Suicidality: Treatment Occurring in Paediatrics)
  
  
• ADDUCE (Attention-Deficit Hyperactivity Disorder Drugs Use Chronic Effects)
  European Union’s Seventh Framework Programme for research, technological development and demonstration, Grant Agreement no. 603016.
  
  
• TACTICS (Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes)
  European Community's Seventh Framework Programme (FP7/2007-2013), Grant Agreement no. 260576.
  
  
• Aggressotype (Aggression subtyping for improved insight and treatment innovation in psychiatric disorders)
  European Union’s Seventh Framework Programme for research, technological development and demonstration, Grant Agreement no. 602805.
  
  
• MATRICS (Multidisciplinary Approaches to Translational Research In Conduct Syndromes)
  European Union’s Seventh Framework Programme for research, technological development and demonstration, Grant Agreement no. 603016.

Targeted Network Meetings

• ‘Emotional lability in mood and behaviour as potential target for pharmacological intervention’ (6 September 2017, after the 30th ECNP Congress, Paris, France).
• Targeted Network Meeting, 4-5 October 2013, Barcelona, Spain.

ECNP School of Child and Adolescent Neuropsychopharmacology
The ECNP School of Child and Adolescent Neuropsychopharmacology has been established to encourage and spread excellence in clinical neuropsychopharmacology among child and adolescent psychiatrists. It is held yearly in Venice, Italy.

• More information here
• Past schools

ECAPN (European Child & Adolescent Psychopharmacology Network)
ECAPN is an initiative of the ECNP Child & Adolescent Neuropsychopharmacology Network.

• ECAPN webpage
• Output of ECAPN
  

ECAPN in Enpr-EMA
The European Child & Adolescent Psychopharmacology Network (ECAPN) has been recognized as an Enpr-EMA Network.

• What is Enpr-EMA?
• ID of ECAPN in the Enpr-EMA database
  

Neuroscience-based Nomenclature Initiative

• The Network worked on the Paediatric information of the NbN Initiative.
  

Recommended Publications

Authors	Year	Title	Journal and link to article
Moreno and Zuddas	2019	Re-thinking treatment targets in child and adolescent psychiatry	European Child & Adolescent Psychiatry
Persico et al.	2015	Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives	European Neuropsychopharmacology

Other applications (unsuccessful in being funded or not yet funded)

• APPLE (Antipsychotics in the paediatric population: limiting exposure)
• OPTI-MED (Establishing optimal ADHD medication strategies across Europe)
• TAPS (Treatment of ADHD in Pre-Schoolers)
• NIOTAS (Neuroimmune Interactions in Obsessive-Compulsive, Tourette’s, ADHD and Autism Spectrum Disorders)
• METPSY (Understanding co-morbidity between cardio-metabolic disorders and severe psychiatric disorders through trans-generational, and early life course approach)
• COBRA (COmputational approaches for Biomarker Identification in ADHD)